Pharmaceuticals
Prestige Consumer Healthcare Posts Strong Q3 Fiscal 2024 Results
Prestige Consumer Healthcare Inc. (NYSE: PBH) reported robust financial results for its third quarter and first nine months ending December...
BioNTech and Autolus Forge Strategic Partnership to Propel CAR-T Cell Therapy Pipeline
In a significant development within the biopharmaceutical sector, BioNTech SE and Autolus Therapeutics plc have announced a strategic collaboration aimed...
Regenxbio’s RGX-121 Trial Achieves Major Milestone in Hunter Syndrome Treatment
Regenxbio Inc. (Nasdaq: RGNX) has announced significant progress in its Phase I/II/III CAMPSIITE® trial of RGX-121 for the treatment of...
